Mergers and Joint Ventures in the Pharmaceutical Industry

Part of the Studies in Regulation book series (STUDREG)


This chapter examines the changes to the EC Merger Regulation which came into force on 1 March 1998, and in particular, the effects which those changes have had on the treatment of all joint ventures including those in the pharmaceutical industry. It also provides some insight into the way in which the European Commission and the UK competition authorities are likely to approach the definition of relevant markets in future mergers and joint ventures in the pharmaceutical industry.


Joint Venture Competition Authority Commission Decision Market Definition Geographic Market 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Palgrave Macmillan, a division of Macmillan Publishers Limited 2003

Authors and Affiliations

There are no affiliations available

Personalised recommendations